R.H. Clayman

1.2k total citations · 1 hit paper
19 papers, 512 citations indexed

About

R.H. Clayman is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R.H. Clayman has authored 19 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 9 papers in Urology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R.H. Clayman's work include Urinary and Genital Oncology Studies (15 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Urological Disorders and Treatments (8 papers). R.H. Clayman is often cited by papers focused on Urinary and Genital Oncology Studies (15 papers), Bladder and Urothelial Cancer Treatments (15 papers) and Urological Disorders and Treatments (8 papers). R.H. Clayman collaborates with scholars based in United States, Egypt and Germany. R.H. Clayman's co-authors include Jason A. Efstathiou, Adam S. Feldman, William U. Shipley, Michael Drumm, Anthony L. Zietman, Andrzej Niemierko, Richard J. Lee, Matthew Wszolek, Niall M. Heney and Douglas M. Dahl and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and The Journal of Urology.

In The Last Decade

R.H. Clayman

16 papers receiving 510 citations

Hit Papers

Long-term Outcomes After Bladder-preserving Tri-modality ... 2017 2026 2020 2023 2017 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
    2017 252 citations Nicholas J. Giacalone, William U. Shipley et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.H. Clayman United States 8 437 227 133 78 51 19 512
Elizabeth M Zehr United States 5 407 0.9× 250 1.1× 66 0.5× 63 0.8× 20 0.4× 7 462
Daher Chade United States 8 561 1.3× 161 0.7× 112 0.8× 172 2.2× 35 0.7× 15 633
S. Holmäng Sweden 7 446 1.0× 121 0.5× 100 0.8× 79 1.0× 41 0.8× 17 500
Roberto Contieri Italy 11 231 0.5× 100 0.4× 43 0.3× 117 1.5× 87 1.7× 63 361
Chih‐Hsiung Kang Taiwan 9 286 0.7× 60 0.3× 81 0.6× 113 1.4× 47 0.9× 17 377
Amiel E. Gilad Israel 4 280 0.6× 118 0.5× 78 0.6× 101 1.3× 24 0.5× 6 371
Michael D. Kinnaman United States 7 217 0.5× 92 0.4× 66 0.5× 105 1.3× 41 0.8× 13 312
Óscar Rodríguez Spain 13 283 0.6× 90 0.4× 65 0.5× 68 0.9× 45 0.9× 27 347
H. Van Randenborgh Germany 11 119 0.3× 85 0.4× 53 0.4× 183 2.3× 43 0.8× 20 346
Alfred Witjes Netherlands 8 133 0.3× 45 0.2× 38 0.3× 90 1.2× 27 0.5× 23 232

Countries citing papers authored by R.H. Clayman

Since Specialization
Citations

This map shows the geographic impact of R.H. Clayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.H. Clayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.H. Clayman more than expected).

Fields of papers citing papers by R.H. Clayman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.H. Clayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.H. Clayman. The network helps show where R.H. Clayman may publish in the future.

Co-authorship network of co-authors of R.H. Clayman

This figure shows the co-authorship network connecting the top 25 collaborators of R.H. Clayman. A scholar is included among the top collaborators of R.H. Clayman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.H. Clayman. R.H. Clayman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dryden‐Peterson, Scott, Sebathu Chiyapo, Jonathan J. Paly, et al.. (2020). BOTSOGO (Botswana Oncology Global Outreach) Tumor Boards: A Model for Global Oncology Education and Collaboration. International Journal of Radiation Oncology*Biology*Physics. 108(3). e402–e402. 1 indexed citations
2.
Liu, Qi, Liliana Gheorghiu, Michael Drumm, et al.. (2018). PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene. 37(21). 2793–2805. 48 indexed citations
3.
Rodin, Danielle, Michael Drumm, R.H. Clayman, et al.. (2017). Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience. Clinical Genitourinary Cancer. 16(1). 21–27.e1. 4 indexed citations
4.
Giacalone, Nicholas J., William U. Shipley, R.H. Clayman, et al.. (2017). Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. European Urology. 71(6). 952–960. 252 indexed citations breakdown →
5.
Miyamoto, David T., Michael Drumm, R.H. Clayman, et al.. (2017). Outcomes and Tolerability of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer in Elderly Patients. International Journal of Radiation Oncology*Biology*Physics. 99(2). S120–S120. 2 indexed citations
6.
Sánchez, Alejandro, Matthew Wszolek, Andrzej Niemierko, et al.. (2017). Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer. The Journal of Urology. 199(2). 407–415. 35 indexed citations
7.
Miyamoto, David T., Michael Drumm, R.H. Clayman, et al.. (2017). Outcomes and tolerability of selective bladder preservation by combined modality therapy for invasive bladder cancer in elderly patients.. Journal of Clinical Oncology. 35(6_suppl). 316–316. 1 indexed citations
8.
Buscariollo, Daniela L., Michael Drumm, Andrzej Niemierko, et al.. (2016). Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience. Practical Radiation Oncology. 7(2). e125–e133. 11 indexed citations
9.
Mak, Kimberley S., Angela Smith, R.H. Clayman, et al.. (2016). Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(5). 1028–1036. 110 indexed citations
10.
Gakis, Georgios, Todd M. Morgan, Siamak Daneshmand, et al.. (2015). Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer.. Journal of Clinical Oncology. 33(15_suppl). 4568–4568.
11.
12.
Giacalone, Nicholas J., R.H. Clayman, Jason A. Efstathiou, et al.. (2015). Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S22–S23. 2 indexed citations
13.
Sánchez-Nadales, Alejandro, Matthew Wszolek, R.H. Clayman, et al.. (2015). MP26-12 INCIDENCE AND MANAGEMENT OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCES AFTER COMPLETE RESPONSE TO COMBINED-MODALITY ORGAN-PRESERVING THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER. The Journal of Urology. 193(4S). 2 indexed citations
14.
Smith, Angela B., R.H. Clayman, Matthew E. Nielsen, et al.. (2015). Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 93(3). S23–S23. 11 indexed citations
15.
Mak, Kimberley S., Angela B. Smith, R.H. Clayman, et al.. (2015). Quality of life in long-term survivors of muscle-invasive bladder cancer.. Journal of Clinical Oncology. 33(7_suppl). 319–319. 20 indexed citations
16.
17.
Gakis, Georgios, Todd M. Morgan, Siamak Daneshmand, et al.. (2014). Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: Results of the international collaboration on primary urethral carcinoma.. Journal of Clinical Oncology. 32(15_suppl). 4587–4587.
18.
Gakis, Georgios, Siamak Daneshmand, Jason A. Efstathiou, et al.. (2013). 943 PROGNOSTIC FACTORS AND OUTCOMES AFTER DEFINITIVE TREATMENT FOR PRIMARY URETHRAL CANCER: RESULTS FROM THE INTERNATIONAL COLLABORATION ON PRIMARY URETHRAL CARCINOMA. The Journal of Urology. 189(4S). 1 indexed citations
19.
Clayman, R.H., William U. Shipley, Andrzej Niemierko, et al.. (2013). Outcomes of Selective Bladder Preservation in the Elderly Treated With Conservative Surgery and Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 87(2). S83–S83. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth M Zehr Breakdown of academic impact, for papers by Daher Chade Breakdown of academic impact, for papers by S. Holmäng Breakdown of academic impact, for papers by Roberto Contieri Breakdown of academic impact, for papers by Chih‐Hsiung Kang Breakdown of academic impact, for papers by Amiel E. Gilad Breakdown of academic impact, for papers by Michael D. Kinnaman Breakdown of academic impact, for papers by Óscar Rodríguez Breakdown of academic impact, for papers by H. Van Randenborgh Breakdown of academic impact, for papers by Alfred Witjes
Rankless by CCL
2026